Supportive care for patients undergoing immunotherapy. – UroToday
|
Supportive care for patients undergoing immunotherapy.
UroToday Immune checkpoint inhibitors, a new class of cancer therapeutic agents, play an important role in the management of melanoma, NSCLC, and other malignancies. A workshop organized by three MASCC Study Groups: Oral Care, Skin Toxicities, and … |
